Designed to provide actionable results while the patient is still present.
WHO recommends a viral load test at 6 months and 12 months, and annually thereafter if the patient is stable on ART1, but few patients receive that level of care.
The m-PIMA™ HIV-1/2 VL test is now commercially available in select countries, and has received CE-IVD marking and WHO prequalification. This product is not available in the United States.
Based on your current location, the content on this page may not be relevant for your country.